Cargando…
Postoperative high-sensitivity troponin T predicts 1-year mortality and days alive and out of hospital after orthotopic heart transplantation
BACKGROUND: Orthotopic heart transplantation (HTX) is the gold standard to treat end-stage heart failure. Numerous risk stratification tools have been developed in the past years. However, their clinical utility is limited by their poor discriminative ability. High sensitivity troponin T (hsTnT) is...
Autores principales: | M’Pembele, René, Roth, Sebastian, Nucaro, Anthony, Stroda, Alexandra, Tenge, Theresa, Lurati Buse, Giovanna, Bönner, Florian, Scheiber, Daniel, Ballázs, Christina, Tudorache, Igor, Aubin, Hug, Lichtenberg, Artur, Huhn, Ragnar, Boeken, Udo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827673/ https://www.ncbi.nlm.nih.gov/pubmed/36624515 http://dx.doi.org/10.1186/s40001-022-00978-4 |
Ejemplares similares
-
Impact of Cardiopulmonary Resuscitation of Donors on Days Alive and Out of Hospital after Orthotopic Heart Transplantation
por: Roth, Sebastian, et al.
Publicado: (2022) -
Impact of Left Ventricular Assist Devices on Days Alive and Out of Hospital in Hemodynamically Stable Patients with End-Stage Heart Failure: A Propensity Score Matched Study
por: Tenge, Theresa, et al.
Publicado: (2022) -
Days alive and out of hospital after left ventricular assist device implantation
por: Roth, Sebastian, et al.
Publicado: (2022) -
Validation of days alive and out of hospital as a new patient-centered outcome to quantify life impact after heart transplantation
por: M’Pembele, René, et al.
Publicado: (2022) -
Life impact of VA‐ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation
por: M'Pembele, René, et al.
Publicado: (2021)